Our 2016 annual report is online!

"In 2016, our research activities at Imagine continued along the same successful path as before, thanks to ever-more inventive ways of meeting our primary challenge: to identify the genes responsible for genetic diseases in children and adults, understand how they work, and develop innovative methods to diagnose them. But we have also made some remarkable therapeutic breakthroughs – notably, initial trials of inhibitors for the treatment of rare auto-immune disorders and the announcement, being made as I write, of our first successful use of gene therapy to treat sickle-cell disease." Prof. Stanislas Lyonnet, Director

Have a look at our latest advances!